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SUMMARY
To estimate incidence and completeness of notification of Legionnaires’ disease (LD) in The
Netherlands in 2000 and 2001, we performed a capture–recapture analysis using three registers :
Notifications, Laboratory results and Hospital admissions. After record-linkage, 373 of the
780 LD patients identified were notified. Ascertained under-notification was 52.2%. Because
of expected and observed regional differences in the incidence rate of LD, alternatively to
conventional log-linear capture–recapture models, a covariate (region) capture–recapture model,
not previously used for estimating infectious disease incidence, was specified and estimated 886
LD patients (95% confidence interval 827–1022). Estimated under-notification was 57.9%.
Notified, ascertained and estimated average annual incidence rates of LD were 1.15, 2.42 and
2.77/100 000 inhabitants respectively, with the highest incidence in the southern region of
The Netherlands. Covariate capture–recapture analysis acknowledging regional differences
of LD incidence appears to reduce bias in the estimated national incidence rate.
INTRODUCTION
Any surveillance system is concerned with the quality
of the data collected, including the degree of ascer-
tainment of affected individuals [1]. A conventional
surveillance system is notification, possibly containing
false-positive cases and often incomplete for true-
positive cases, as described for Legionnaires’ disease
(LD) [2, 3].
LD is a serious, possibly fatal, pneumonia caused
by Legionella spp., occurring in sporadic cases and
outbreaks [4, 5]. Under the present legislation regard-
ing infectious diseases in The Netherlands, LD is
placed in category B. This group of infectious diseases
has to be notified within 24 h to the Municipal Public
Health Service by the diagnosing physician. The
Municipal Public Health Service forwards this in-
formation to the Register of Notifiable Infectious
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Diseases at the Office of the Health Care Inspectorate
where national data are aggregated for analysis, moni-
toring, public health intervention or policy making.
Since 1999 an average of 230 LD patients were
notified in The Netherlands annually. The average
national annual incidence rate was 1.4 LD patients
per 100 000 inhabitants, almost three times higher
than the average annual incidence rate in the United
States and the United Kingdom [6, 7]. However, the
incidence rate based on notifications varies consider-
ably per province [8]. Under-diagnosis and under-
notification are likely. This can obscure the true
burden of LD, hamper the detection of clusters of LD
patients and hinder good investigations into the poss-
ible source of legionella infections. The Dutch Health
Council estimated an annual number of 800 LD
patients. This number is based on the annual number
of cases of pneumonia in The Netherlands (110 000)
of whom 15% require hospital admission (16 000) of
which 5% is caused by Legionella spp. (800) [9].
Record-linkage is important for assessing the
quality and completeness of infectious disease regis-
ters, i.e. comparing patient data across multiple
registers [10]. Completeness of notification can be
assessed by comparison with case-ascertainment, i.e.
the total number of patients observed in at least one
register, or the estimated total number of patients
obtained by capture–recapture analysis. The total
number of individuals present in one or more regis-
trations does not necessarily reflect a reliable approxi-
mation of the true number of cases. The purpose of
capture–recapture analysis is to assess the number
of cases that are not registered. In an article published
in 1972, Stephen Fienberg demonstrated how this
number of unobserved cases could be estimated, using
log-linear analysis [11]. For capture–recapture analy-
sis, according to Fienberg, the availability of data from
at least three different, possibly incomplete, partially
overlapping and preferably, but not necessarily,
independent sources is needed [12–16]. The data can
be put in a 2r2r2 contingency table, indicating the
absence or presence of a case in each of the registers.
This table has one empty cell, corresponding to the
number of cases never registered. Based on certain
assumptions, which will be discussed later, capture–
recapture analysis aims at obtaining an estimate of
the unregistered number of patients in the empty
cell from the available data in the other cells. This
estimate can be found under the best fitting and most
parsimonious log-linear model, as explained later.
Finally, the total number of individuals is the number
of registered cases plus the estimated number of non-
registered patients. Capture–recapture methods have
been used to estimate the total number of patients
with LD and other infectious diseases [2, 3, 17].
The validity of capture–recapture analysis depends
on possible violation of the underlying assumptions
and one focus is to establish which method is most
appropriate for specific datasets [15]. Usually, log-
linear modelling of data from at least three linked
registers is the preferred capture–recapture method
because it can reduce bias due to inter-dependencies
between two registers [13, 17] Stratified capture–
recapture analysis according to categorical covariates
associated with the probability of capture in a register
can further reduce bias [11, 12, 14, 16]. An alternative
is to include these covariates, e.g. demographic, diag-
nostic or prognostic variables, in a log-linear co-
variate capture–recapture model but these models
have rarely been used to estimate human disease
incidence [18, 19].
This study aims to estimate incidence and com-
pleteness of notification of LD in The Netherlands
in 2000 and 2001 using record-linkage of three data
sources and capture–recapture analysis.
MATERIALS AND METHODS
Data sources and patient identifiers
Three LD data sources were used:
(1) Notification. Patients notified by their physician
to the Health Care Inspectorate. A uniform ques-
tionnaire collected additional information from
local Public Health Services processing the noti-
fications.
(2) Laboratory. Patients with a specified positive
laboratory test result reported by the clinical
microbiologists in a survey among all clinical
microbiology laboratories after obtaining per-
mission for this survey from the Dutch Society for
Microbiology and supported by the Inspector-
General for Infectious Diseases of the Health
Care Inspectorate. Positive laboratory test results
were classified as either confirmed (culture, urine
antigen test or a fourfold rise in antibody titre
[o128 IU] against Legionella spp. in paired acute
and convalescent serum samples) or probable
[PCR, a high titre (o256 IU) against Legionella
spp. in one serum sample or direct fluorescent
antibody staining], according to the European
Working Group for Legionella Infections
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(EWGLI) definitions. Patients with LD only
known to the Hospital register were classified as
cases with unknown laboratory verification.
(3) Hospital. Hospitalized patients recorded in the
National Morbidity Registration by Prismant,
covering all hospitals in The Netherlands with:
(a) an International Code for Diseases (ICD-9
code) for all forms of pneumonia (ICD-9
codes 480.0–487.0) for individuals known to
Notification and/or Laboratory.
(b) An ICD-9 code 482.8 for individuals only
known to Hospital.
ICD-9 has no specific code for LD and, as reported
from other countries, in The Netherlands ICD-9 code
482.8 (pneumonia due to other specified bacteria)
is used for LD patients [20]. Hospital records coded
as 482.8 can therefore include false-positive cases,
mainly patientswithEscherichia colipneumonia, a rare
nosocomial disease, predominantly occurring among
intensive-care patients. Data on the annual number of
E. coli pneumonia patients in The Netherlands are not
available. Based upon an estimated annual number
of 60 000 intensive-care admissions and an estimated
E. coli pneumonia incidence of 1/1000 intensive-care
admissions (derived from a random survey among
intensive-care consultants in The Netherlands), the
estimated annual number of E. coli pneumonia
patients is 60. This number is used to correct the
number of patients only known to Hospital. Because
proxy code 482.8 is used for cross-validation and
collection of additional information, uniform ques-
tionnaires requested all chest physicians to report
hospitalized LD patients in 2000 and 2001.
For all patients in each register it was attempted to
collect date of birth, postal code or town of residence,
sex and date of notification (and first day of illness),
first laboratory sample or hospital admission as
personal identifiers to be used in all record-linkage
procedures. Duplicate entries in each register were
deleted.
Case-definition and study period
LD patients are defined as all ascertained (noti-
fied, laboratory-reported or hospitalized) and un-
ascertained LD patients. Notified LD patients with
a first day of illness in 2000 and 2001 were included
in the study. For inclusion of patients known to
Laboratory and/or Hospital the laboratory sample
date, hospital admission date or first known of both
dates were used as proxy for first day of illness.
Through examining the registers 1 month before and
after the study period, all registers were corrected for
late notification or laboratory results, as described
previously [17].
Record-linkage and stratification
Record-linkage was performed manually using the
patient identifiers, proximity of dates and geographi-
cal information found in the three registers. In case
of doubt consensus was sought between two inves-
tigators. Because of expected geographical differences
in incidence of LD, after record-linkage, on the basis
of the provinces of The Netherlands, ascertained LD
patients were stratified into four regions: North
(1 671534 inhabitants), East (4 467 527 inhabitants),
West (5 955 299 inhabitants) and South (3 892 715 in-
habitants) (Fig.). Correction for the estimated number
of E. coli pneumonia patients in the different regions
was proportional to the regional division of the total
number of patients only ascertained in Hospital.
Coverage rates and capture–recapture analysis
The ascertained register-specific coverage rate is de-
fined as the number of LD patients in each register
Fig. The four regions of The Netherlands.
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divided by the case-ascertainment, expressed as per-
centage. The total number of un-ascertained LD
patients was estimated on the basis of the distribution
of the ascertained cases over the three registers.
For internal validity analysis we used two-source
capture–recapture analysis, as explained elsewhere
[21]. Briefly, by two-source capture–recapture analy-
sis the estimated total number of cases, Nest, equals
the number of cases on register A, NA, times the
number of cases on register B, NB, divided by the
overlap of the two registers, Nboth (Nest=NArNB/
Nboth, also known as the Petersen estimator equa-
tion). Approximately unbiased estimates of Nest are
expected when the registers are large. To correct
for bias caused by small registers Chapman proposed
the Nearly Unbiased Estimator, which can be ex-
pressed as Nest=[(NA+1)r(NB+1)/(Nboth+1)] – 1
[13, 22, 23].
The independence of registers and other assump-
tions underlying capture–recapture analysis were
described previously [17]. Specific interdependencies
between the three registers, causing bias in two-source
capture–recapture estimates, are probable. Using
SPSS statistical software (version 13.0; SPSS Inc.,
Chicago, IL, USA), conventional total and stratified
three-source log-linear capture–recapture analysis
was employed taking possible interdependencies and
heterogeneity into account, as previously described
[17]. Alternatively to capture–recapture analysis
stratified by region, a log-linear covariate capture–
recapture model with one covariate, region, was
specified [18, 19, 24]. Other covariates considered will
be discussed later. The best-fitting models were
identified using the likelihood ratio test (G2). The null
hypothesis in the likelihood-ratio goodness-of-fit test
is that the specified model holds and the alternative
is that it does not hold. If the null hypothesis does
not need to be rejected (e.g. P>0.05) this means
that there is no evidence that the specified model is in
disagreement with the data. The lower the value of G2
the better is the fit of the model. In the log-linear
estimation procedure model selection follows model
fitting, i.e. to identify the models that are clearly
wrong and select from a number of acceptable models
the most appropriate. For model selection we used
Akaike’s Information Criterion (AIC) which can be
expressed as AIC=G2 – 2 degrees of freedom (D.F.)
[25]. The first term, G2, is a measure of how well the
model fits the data and the second term, 2 D.F., is a
penalty for the addition of parameters (and hence
model complexity). A second information criterion
used was the Bayesian Information Criterion (BIC)
which can be expressed as BIC=G2 – (ln Nobs) (D.F.),
whereNobs is the total number of observed individuals
[26]. Relative to the AIC, the BIC penalizes complex
models more heavily. In general, in the log-linear
capture–recapture estimation procedure the least
complex, i.e. the least saturated (in other words the
most parsimonious) model, whose fit appears ad-
equate, is preferred [13]. Since the G2 of the saturated
model is zero and has no degrees of freedom left,
the AIC and BIC are also zero and models with a
negative AIC and BIC are preferred although this
does not necessarily mean that the estimate is correct.
The estimated register-specific coverage rate is de-
fined as the number of LD patients in each register
divided by the estimated total number of LD patients,
expressed as percentage.
RESULTS
Notification system
In the notification register from the Health Care
Inspectorate 358 LD patients were recorded. An
additional 15 patients were reported through the
questionnaires from local public health services pro-
cessing the notifications, giving a total of 373 notified
LD patients.
Laboratory survey
Questionnaires were received from 36 out of the
48 laboratories (response rate 75%). Based on popu-
lation estimates the cooperating laboratories served
81.2% of the Dutch population. A total of 261
patients with a positive test for Legionella spp. were
reported. Of these patients 186 (71.3%) were notified.
Additional information on laboratory diagnosis was
available for another 127 patients through Public
Health Service or chest physician questionnaires,
bringing the total number of patients with known
laboratory results to 388.
Hospital records
From 385 chest physicians in The Netherlands
179 replies were received (response rate 46%), the
majority indicating that the requested information
could not be retrieved or no LD patients were admit-
ted. Chest physicians reported 44 LD patients, all of
them also known to Notification and/or Laboratory.
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Out of 448 LD patients in Notification and/or
Laboratory, 331 (73.9%) could be linked to the
National Morbidity Registration pneumonia records.
Of the linked LD patients 79 (23.9%) were classified
as either ‘pneumonia not specified’ (ICD-9 code 486,
63 cases), ‘pneumonia due to other specified organ-
ism’ (ICD-9 code 483, nine cases) or ‘pneumococcal
pneumonia’ (ICD-9 code 481, seven cases). The re-
maining 252 linked patients (76.1%) had ICD-9 code
482.8, the assigned code for LD. Another 452
patients, unknown toNotification and/or Laboratory,
were identified in Hospital with ICD-9 code 482.8.
This number was adjusted to 332 LD patients after
deduction of an estimated number of 120 E. coli
pneumonia patients in the two years studied, also re-
corded under ICD-9 code 482.8.
Epidemiological results
Table 1 shows the epidemiological characteristics of
447 LD patients in Notification and/or Laboratory
(one patient had insufficient data). The mean age was
54 years (S.D.= 14 years). The recorded case-fatality
rate was 5.6%. The mean duration between onset of
disease and microbiological diagnosis was 12 days
(median 6 days). The mean duration of hospital
admission was 19 days (median 13 days).
Table 2 shows the number and proportion per
region of the different laboratory tests for Legionella
spp. There are differences between the four Dutch
regions in laboratory diagnostic approach. In region
North no culture results were reported. In region
West a low proportion of fourfold rise in antibody
titre and PCR results were reported and more patients
had unknown test results, probably the result of non-
participation of some larger laboratories. In region
South a high proportion of a fourfold rise in antibody
titre and PCR results were reported, probably the
result of a major reference laboratory in that region.
Case-ascertainment
Table 3 shows the distribution of the 780 ascertained
LD patients over the three registrations after record-
linkage, in total and stratified by region. The ascer-
tained register-specific coverage rate of Notification,
Laboratory and Hospital was 47.8% (373/780),
33.5% (261/780) and 85.0% (663/780) respectively.
The ascertained under-notification was 52.2%.
Table 4 shows the number of notified and ascertained
LD patients, the average annual incidence rate by
notification and by case-ascertainment and the pro-
portion of the ascertained patients notified, in total
and stratified per region. The average national annual
incidence rate by notification was 1.15/100 000 and by
case-ascertainment 2.42/100 000. The regional annual
incidence rates differ, with a 100% difference between
the highest and lowest regional incidence rate based
on notification, reducing to 50% difference after
record-linkage. Based upon the notification data the
low incidence rate in region North partly results from
under-notification but the notified and ascertained
incidence rates in region South were higher than in the
rest of The Netherlands (P<0.0001).
Capture–recapture analysis
Internal validity analysis by two-source capture–
recapture analysis on Notification and Hospital and
on Laboratory and Hospital both estimate 865 LD
patients through Chapman’s Nearly Unbiased Esti-
mator. The considerable lower capture–recapture
estimate obtained with Notification and Laboratory
(523 LD patients) indicates a larger positive associ-
ation between this pair than between the other pairs,
resulting in an estimate more biased downwards.
The best-fitting three-source log-linear capture–
recapture model was the saturated model, i.e. the
model including all two-variable associations and
assuming absent three-way interaction, which yielded
an estimate of 1253 LD patients [95% confidence in-
terval (CI) 1019–1715]. Estimated under-notification
was 70.2%. To acknowledge the geographical differ-
ences capture–recapture analysis stratified by region
was performed. For all regions apart from region East
a more parsimonious model, containing only one
two-way interaction (between Notification and Lab-
oratory), was selected as best-fitting model, with
totals of 78, 327 and 277 LD patients and incidence
rates of 2.33, 2.75 and 3.56/100 000 inhabitants
for regions North, West and South respectively. For
region East a saturated model was selected that esti-
mated an unexpectedly high number of 650 LD
patients with a wide 95% CI of 283–2382 patients.
As an alternative to the stratified capture–recapture
analysis we specified a log-linear covariate (region)
capture–recapture model. The covariate model
that served as a starting point contained, apart from
the main effects for region and the three registers, the
Region-Notification, Region-Laboratory, Region-
Hospital, Notification-Laboratory, Notification-
Hospital, Laboratory-Hospital two-variable terms.
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In this model we allow for regional differences in the
number of cases in the three registers, but not for
interaction with other effects per stratum, as the
association between the registers is assumed equal
across regions. This model fits the data reasonably
well (G2=22.1, D.F.=9, P=0.009) and estimates 932
LD patients with a narrower 95% CI of 851–1106,
reducing statistical uncertainty. Inspection of the
misfit for individual cells showed a large adjusted
residual for LD patients only known to Laboratory
in region East. After including a separate parameter
for this single cell we obtain a good fitting model
Table 1. Epidemiological characteristics of 447 Legionnaires’ disease patients in The Netherlands*
Male (n=319) Female (n=128) Total (n=447)
Age category (yr)
0–19 0.3% (1/318) 4.7% (6/128) 1.6% (7/446)
20–39 11.9% (38/318) 18.0% (23/128) 13.7% (61/446)
40–59 55.3% (176/318) 43.8% (56/128) 52.0% (232/446)
60–79 28.9% (92/318) 30.5% (39/128) 29.4% (131/446)
o80 3.5% (11/318) 3.1% (4/128) 3.4% (15/446)
Seasonal pattern : month of disease onset
Jan.–Feb. 7.8% (25/319) 10.2% (13/128) 8.5% (38/447)
Mar.–Apr. 11.0% (35/319) 10.9% (14/128) 11.0% (49/447)
May–June 19.4% (62/319) 14.1% (18/128) 17.9% (80/447)
July–Aug. 26.6% (85/319) 25.0% (32/128) 26.2% (117/447)
Sep.–Oct. 21.9% (70/319) 31.3% (40/128) 24.6% (110/447)
Nov.–Dec. 13.2% (42/319) 8.6% (11/128) 11.9% (53/447)
Travel abroad during incubation period#
Travel abroad: yes 53% (169/319) 50% (64/128) 52% (233/447)
Countries involved
Turkey 20% (33) 30% (19) 22% (52)
France 23% (39) 8% (5) 19% (44)
Spain 12% (21) 13% (8) 12% (29)
Italy 8% (14) 11% (7) 9% (21)
Germany 7% (12) 9% (6) 8% (18)
Portugal 2% (4) 2% (1) 2% (5)
Greece 2% (4) 2% (1) 2% (5)
Belgium 3% (5) 0% 2% (5)
Rest of Europe 11% (18) 13% (8) 11% (26)
Americas 5% (9) 6% (4) 6% (13)
Asia 3% (5) 2% (1) 3% (6)
Africa 0% 3% (2) 1% (2)
Unknown 3% (5) 3% (2) 3% (7)
Legionella spp.
L. pneumophila serogroup 1 61.2% (170/278) 54.5% (60/110) 59.3% (230/388)
L. pneumophila serogroups 2–12 2.5% (7/278) 1.8% (2/110) 2.7% (9/388)
L. non-pneumophila 3.2% (9/278) 0.9% (1/110) 2.6% (10/388)
Unknown 31.7% (88/278) 42.7% (47/110) 34.8% (135/388)
Laboratory confirmation$
At least two confirming tests 22.0% (61/277) 17.3% (19/110) 20.7% (80/387)
One confirming test 56.0% (155/277) 56.4% (62/110) 56.1% (217/387)
Only probable test 22.0% (61/277) 26.4% (29/110) 23.3% (90/387)
* From 447 patients sufficient data was available for analysis ; sometimes one or two variables are missing.
# Rest of Europe : Austria, Croatia, Cyprus, England, Hungary, Ireland, Luxembourg, Moldavia, Poland, Slovakia,
Switzerland, Czech Republic, Yugoslavia ; Americas : Netherlands Antilles, Brazil, Canada, Dominican Republic, Mexico,
Peru, USA, Venezuela ; Asia : China, Indonesia, Japan, Kazakhstan, Malaysia ; Africa : Morocco and Tunis.
$ Confirmed laboratory diagnosis : positive culture, positive urine antigen test or a fourfold rise in antibody titre against
Legionella spp. in paired acute and convalescent serum samples, o128 IU. Probable laboratory diagnosis : positive PCR,
a high titre in one serum sample against Legionella spp.,o256 IU, or direct fluorescent antibody staining of the organism.
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(G2=5.7, D.F.=8, P=0.686). The estimated number
of LD patients is 886 (95% CI 827–1022), similar to
the two internal validity estimates with least assumed
interdependence.
The estimated register-specific coverage rate of
Notification, Laboratory and Hospital was 42.1%
(373/886), 29.5% (261/886) and 74.9% (663/886)
respectively. The estimated under-notification was
57.9%. The estimated average annual incidence rate
of LD was 2.77/100 000.
A sensitivity analysis, assuming double or half
the number of false-positive cases due to E. coli
pneumonia only known to Hospital, estimated the
number of LD patients to range between 727 (95% CI
689–813) and 966 (95% CI 896–1126).
DISCUSSION
After record-linkage and log-linear covariate
capture–recapture analysis of three registers of LD
in 2000 and 2001 in The Netherlands we found a
notified, ascertained and estimated annual incidence
rate of 1.15, 2.42 and 2.77 cases/100 000 inhabitants
Table 2. Number and proportion of the laboratory test results for Legionella spp. in The Netherlands in 2000
and 2001, in total and stratified per region
Confirmed laboratory test
Probable laboratory test
Culture
(%)
Urine antigen
test (%)
Fourfold
rise in
antibody
titre (%)
Positive
PCR (%)
High single
titre (%) DFA# Unknown
All Legionella
pneumonia (100%
of population)*
71 (100%) 216 (100%) 92 (100%) 33 (100%) 119 (100%) 0 56/441 (13%)
Region
North (11%) 0 (0%) 15 (7%) 14 (15%) 2 (6%) 8 (7%) 0 3/34 (9%)
East (18%) 16 (22%) 61 (28%) 23 (25%) 5 (15%) 33 (28%) 0 14/123 (11%)
West (41%) 31 (44%) 78 (36%) 17 (19%) 3 (9%) 30 (25%) 0 31/149 (21%)
South (30%) 24 (34%) 62 (29%) 38 (41%) 23 (70%) 48 (40%) 0 8/135 (6%)
* For 441 patients information of region was known.
# Direct fluorescent antibody staining.
Table 3. Ascertained total number of Legionnaires’ disease (LD) patients and number stratified by region
of The Netherlands in three linked LD registrations in 2000 and 2001, after proportional adjustment for
false-positive Escherichia coli pneumonia patients only known to the Hospital register
No.
ascertained
Only
NOT*
Only
LAB#
Only
HOSP$
NOT and
LAB
NOT and
HOSP
LAB and
HOSP
NOT and
LAB and
HOSP
All LD
patients
780 56 30 332 31 131 45 155
Region
North· 69 3 2 35 2 6 8 13
East· 185 13 13 62 3 42 7 45
West· 286 23 5 136 7 55 14 46
South· 234 13 9 99 19 28 15 51
* NOT, Notification register (373 patients).
# LAB, Laboratory register (261 patients).
$ HOSP, Hospital admission register. The proportional correction for the Escherichia coli pneumonia patients in regions
North, East, West and South is 13, 22, 49 and 36 patients respectively (663 patients).
· For six LD patients the place of residence unknown.
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respectively. Ascertained and estimated under-
notification was 52.2% and 57.9% respectively. This
indicates the need for more consistent notification,
e.g. through treatment of LD by a limited group of
clinicians, familiar with notification. The southern
part of The Netherlands had a higher notified, ascer-
tained and estimated incidence rate of LD.
Legionella pneumonia might be responsible for
0–14% of all nosocomial pneumonias and for 2–16%
of all community-acquired pneumonias [27]. In The
Netherlands legionella pneumonia is reportedly re-
sponsible for 7% of all nosocomial pneumonias and
2–8% of all community-acquired pneumonias in
hospitalized patients [28–30]. Under-notification of
LD is estimated at 67% in France, 90% in England
and 95% in the United States [3, 31–33]. At 57.9%
we estimated a lower under-notification in The
Netherlands, possibly influenced by increased aware-
ness after a major outbreak or increased use of the
urine antigen test (although this use is proportionally
still low compared to the average EWGLI data for
Europe) [4, 31]. Among patients in the laboratory sur-
vey with positive legionella results under-notification
was 28.7%, much lower than reported in France [2].
Parallel to mandatory notification by clinicians, many
Dutch laboratories report positive results voluntarily
to the public health services, which reduces under-
notification of LD and other infectious diseases. The
ascertained and estimated register-specific coverage
rates for the laboratories would be higher with a better
response. Record-linkage improved completeness of
information in the linked dataset but, unlike labora-
tories, clinicians are not a useful source of additional
information.
Several assumptions must be met for valid results
of three-source log-linear capture–recapture models
and limitations of capture–recapture analysis are
described by others [13, 16, 34–39]. Violation of the
closed population assumption is assumed limited for
LD as opportunities for notification, laboratory veri-
fication or hospitalization are largely determined
within a short period of time, but could result in over-
estimation of the number of patients. Due to lack of
a unique patient identification number used in all
registrations and incomplete information on personal
identifiers in some records, imperfect record-linkage
cannot be excluded but balanced misclassification can
still result in unbiased numbers in each category.
Limitations of capture–recapture studies due to lack
of a uniform and unambiguous case-definition and
variable specificity of registers are described elsewhere
[36, 40]. The notification criteria in The Netherlands
requires a clinical diagnosis of pneumonia and a con-
firmed or probable laboratory diagnosis. However,
for 187 (50.1%) notified patients and 463 (69.8%)
hospitalized patients no laboratory-verification was
found, although part of these patients could be
microbiologically diagnosed in a non-participating
laboratory or abroad or, due to imperfect record-
linkage, could not be linked to Laboratory. Likewise
Table 4. Number of notified and ascertained Legionnaires’ disease (LD) patients, the average annual LD
incidence rate (n/100 000) and the proportion of the ascertained LD patients notified in The Netherlands and
stratified per region
Notification (passive surveillance) Record-linkage (case-ascertainment)
Number
of notified
LD patients*
Average annual
incidence rate
(N/100 000)
Number of
ascertained
LD patients
Average annual
incidence rate
(N/100 000)
Proportion
notified
All LD patients
(15 987 075 inhabitants)
373 1.15 780 2.42 47.8%
Region North
(1 671 534 inhabitants)
24 0.72 69 2.06 34.8%
Region East
(4 467 527 inhabitants)
103 1.15 185 2.07 55.7%
Region West
(5 955 299 inhabitants)
131 1.10 286 2.40 46.0%
Region South
(3 892 715 inhabitants)
111 1.43 234 3.01 47.4%
* The information on region was missing for four LD patients.
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Laboratory may contain cases without pneumonia
and cases diagnosed on a single high antibody titre,
a test with a low positive predictive value [3, 29].
The 79 linked patients in Hospital with another
pneumonia ICD-9 code than 482.8 are probably
miscoded but some could be false-positive cases.
Violation of the perfect positive value of the hospital
episode registers is always a reason for concern in
capture–recapture studies on infectious diseases and
should be addressed critically, even when specific
disease codes are used, e.g. for tuberculosis in ICD-9
[41–44]. We have corrected for imperfect positive
predictive value for Hospital. Possible bias as a result
of correction for other hospitalized patients with
ICD-9 code 482.8 is reflected in the confidence inter-
vals of the sensitivity analysis. Conventional log-
linear capture–recapture analysis for The Netherlands
and region East selected the saturated model, with
an unexpectedly high estimate in region East. When
saturated capture–recapture models are selected by
any criterion investigators should be particularly
cautious about the associated outcomes [16, 44–46].
We selected the three-source covariate capture–
recapture model with equal two-way interactions
across the regions as the best-fitting model. Internal
validity analysis and analyses stratified by region indi-
cate dependence betweenNotification and Laboratory
as the dominant interaction. Positive three-way in-
teraction across sources, causing underestimation of
the number of LD patients, cannot be incorporated in
the selected model but is arguably limited. Regional
heterogeneity in the probability of being captured
in the different registers was expected and observed
[3, 8]. Covariate capture–recapture models have
been used only rarely to estimate disease incidence
but appear to reduce bias due to heterogeneity and
result in plausible estimates of the total number of
cases, e.g. in simulations [18, 19]. Inclusion of other
covariates than region in the model, such as age or
method of laboratory diagnosis, could have further
reduced bias. In France, apart from region, method of
diagnosis was identified as a variable with hetero-
geneity of capture [3]. However, proportional correc-
tion for E. coli pneumonia patients in Hospital, as
performed for the regional stratification, was not
feasible. Bias due to exclusion of these and unobserved
possibly relevant covariates from the model can not
be excluded.
Different characteristics of diseases, the patients
and their registers can introduce various degrees of
register interdependence and population heterogeneity
into capture–recapture analysis, influencing model
preference. This study shows that in The Netherlands
for LD there is considerable interdependence be-
tween Notification and Laboratory and confirms
geographical heterogeneity. Log-linear covariate
capture–recapture analysis with region as covariate
appears to reduce bias in the estimated number of LD
patients. To our knowledge this is the first covariate
capture–recapture study performed for infectious
disease surveillance. Further research is needed into
the causes of the geographical differences of LD inci-
dence rates.
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